RenovaCare IncOTC Pink - Current Information:RCAR
- LAST PRICE0.1201
- TODAY'S CHANGE (%)-0.0099 (-7.6154%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.1201 / 0.1300
- Day Range
- 52 Week Range
- Volume300
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RCAR |
|---|---|---|
| 01:50 ET | 300 | 0.1201 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
RenovaCare Inc | 10.5M | -1.8x | --- |
Galmed Pharmaceuticals Ltd | 10.7M | -0.6x | --- |
Avail Scientific Inc | 10.2M | -1.7x | --- |
Biomx Inc | 10.1M | -0.3x | --- |
Bio Path Holdings Inc | 11.1M | -0.7x | --- |
Theriva Biologics Inc | 11.1M | -0.5x | --- |
Company Information
RenovaCare, Inc. is a development-stage biotech and medical device company. The Company is focused on the research, development and commercialization of autologous cellular therapies for the regeneration of human organs and tissues. The Company’s product under development targets the skin. The Company's flagship technology, the CellMist System, renders single-cell suspensions of tissue-specific pluripotent cells from donor tissues through sequential protease digestions. The RenovaCare CellMist System facilitates healing of wounds or other afflicted tissues when applied as a gentle cell mist using the RenovaCare SkinGun. The Company’s CellMist System consists of the CellMist cell suspension derived by enzymatic digestion of a patient’s own skin tissue applied topically with its electronic SkinGun spray device to deliver a single-cell mist onto the patient's burn wound. The Company's wholly owned subsidiary is RenovaCare Sciences Corp.
Contact Information
- Headquarters
- 9375 E. Shea Blvd., Suite 107-ASCOTTSDALE, AZ, United States 85260
- Phone
- 800-755-5815
- Fax
- ---
Executives
- Chairman of the Board, Interim President, Chief Executive Officer, Interim Chief Financial Officer, Secretary
- Harmel Rayat
- Chief Scientific Officer
- Robin Robinson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 87.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-0.07 |
Book Value | $0.03 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
